Stock Trading History of Federico Charles

The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Federico Charles since year 2005. The trader's CIK number is 1213215. At the time of this reporting, Federico Charles is the Director of Biomimetic Therapeutics, Inc. . (stock ticker symbol BMTI). See this page for all insider trading activities at Biomimetic Therapeutics, Inc. .
Note that in the past FEDERICO CHARLES also reported insider trading activities as an insider of the following companies:

Insider Activities at Biomimetic Therapeutics, Inc. (BMTI)
Insider Activities at Mako Surgical Corp. (MAKO)
Insider Activities at Orthofix International N V (OFIX)

Stock purchases, sales, and option exercises reported by insider *Federico Charles* since 2005.
Trade Date	Symbol	Company Name (Issuer)	Trade Type	Shares	Price ($)	Value ($)
2008-03-28	BMTI	Biomimetic Therapeutics, Inc.	Purchase	1,075	9.24	9,937
2008-02-20	MAKO	Mako Surgical Corp.	Purchase	10,000	10.00	100,000
2006-12-05	OFIX	Orthofix International N V	Option Exercise	43,800	40.40	1,769,520
2006-12-05	OFIX	Orthofix International N V	Sale	43,800	45.10	1,975,282
2006-08-30	OFIX	Orthofix International N V	Option Exercise	125,100	17.88	2,236,162
2006-08-31	OFIX	Orthofix International N V	Option Exercise	124,900	30.66	3,828,965
2006-08-30	OFIX	Orthofix International N V	Sale	125,100	39.82	4,981,386
2006-08-31	OFIX	Orthofix International N V	Sale	124,900	39.41	4,922,597
2006-03-08	OFIX	Orthofix International N V	Option Exercise	2,500	17.88	44,687
2006-03-08	OFIX	Orthofix International N V	Sale	2,500	43.00	107,500
2006-03-03	OFIX	Orthofix International N V	Sale	3,100	43.60	135,160
2006-03-03	OFIX	Orthofix International N V	Option Exercise	3,100	17.88	55,412

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Federico Charles (Director of Biomimetic Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.